{"id":632717,"date":"2026-09-22T18:58:21","date_gmt":"2026-09-22T18:58:21","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/632717\/"},"modified":"2026-09-22T18:58:21","modified_gmt":"2026-09-22T18:58:21","slug":"glp-1-drugmakers-sued-over-sudden-vision-loss-risk-reports","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/632717\/","title":{"rendered":"GLP-1 drugmakers sued over sudden vision loss risk: Reports"},"content":{"rendered":"<p> <img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/ie\/wp-content\/uploads\/2026\/09\/hadczy8k5wzltr6u.jpg\" alt=\"Controversy surrounding diabetes drug, Ozempic, being used for weight loss\" class=\"sr-only\" data-v-892ef6a8=\"\"\/>    <img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/ie\/wp-content\/uploads\/2026\/09\/hadczy8k5wzltr6u.jpg\" alt=\"Controversy surrounding diabetes drug, Ozempic, being used for weight loss\" loading=\"eager\" fetchpriority=\"high\" class=\"vod-poster-image vod-poster-image--embedded\" data-v-a3924c54=\"\"\/>     <\/p>\n<p data-v-94395e58=\"\">A civil lawsuit has been filed against GLP-1 drugmakers over the potential risk of sudden vision loss, according to multiple reports.\u00a0<\/p>\n<p>   Lawsuits filed against GLP-1 drugmakers <\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">Big picture view:<\/p>\n<p data-v-94395e58=\"\">Dozens of patients have joined a civil lawsuit brought against Novo, the maker of Wegovy and Ozempic, according to the<a href=\"https:\/\/www.wsj.com\/health\/pharma\/patients-sue-glp-1-drugmakers-over-risk-of-sudden-vision-loss-f60d7acb\" rel=\"nofollow noopener\" target=\"_blank\"> Wall Street Journal.\u00a0<\/a><\/p>\n<p data-v-94395e58=\"\">The lawsuit claimed that patients who were taking either of the two popular weight-loss and diabetes drugs developed NAION, a condition that can lead to sudden and sometimes permanent vision loss.\u00a0<\/p>\n<p data-v-94395e58=\"\">Similar lawsuits against Eli Lilly, the maker of Zepbound, were filed claiming the company failed to adequately warn patients of the risks. Those cases are still pending.\u00a0<\/p>\n<p> What studies say about GLP-1s and vision loss\u00a0 <\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">The backstory:<\/p>\n<p data-v-94395e58=\"\"><a href=\"https:\/\/www.aao.org\/eyenet\/article\/naion-diagnosis-and-management\" rel=\"nofollow noopener\" target=\"_blank\">Non-arteritic anterior ischaemic optic neuropathy (NAION)\u00a0<\/a>is a rare eye condition that can lead to sudden vision loss due to lack of blood flow.<\/p>\n<p data-v-94395e58=\"\"><a href=\"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2830475\" rel=\"nofollow noopener\" target=\"_blank\">Recent studies\u00a0<\/a>analyzed how semaglutide and tirzepatide \u2014 which include popular drugs like Ozempic, Wegovy, Mounjaro and Zepbound \u2014 impacted eye health in Americans with type 2 diabetes over a two-year period.<\/p>\n<p data-v-94395e58=\"\">One study found a modest risk of NAION in association with semaglutide and tirzepatide.<\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">By the numbers:<\/p>\n<p data-v-94395e58=\"\">Out of more than 159,000 study participants with type 2 diabetes, 35 developed NAION, compared to 19 people in the comparison group.<\/p>\n<p data-v-94395e58=\"\">Researchers also noted an increased risk of developing &#8220;other optic nerve disorders,&#8221; identified in 93 patients.<\/p>\n<p> <img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/ie\/wp-content\/uploads\/2026\/09\/glp1.jpg\" alt=\"\" loading=\"lazy\" fetchpriority=\"auto\" width=\"932\" height=\"524\" data-v-2fe2fe3e=\"\"\/> <\/p>\n<p data-v-2fe2fe3e=\"\">FILE &#8211; Photo illustration of a group of weight loss injection pen medications. (Photo by: Michael Siluk\/UCG\/Universal Images Group via Getty Images) <\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">The other side:<\/p>\n<p data-v-94395e58=\"\">While individuals with type 2 diabetes on GLP-1s showed a modestly increased risk of diabetic retinopathy, the researchers concluded that fewer patients experienced sight-threatening complications from the disease.<\/p>\n<p original-article-post=\"\" origination_station=\"LNFX\" data-v-ec26887a=\"\" data-v-94395e58=\"\">What&#8217;s next:<\/p>\n<p data-v-94395e58=\"\">Further research is needed on this matter, but for now, clinicians and patients are encouraged to make &#8220;informed choices&#8221; when it comes to using GLP-1s,\u00a0<a href=\"https:\/\/www.aao.org\/newsroom\/news-releases\/detail\/do-glp-1-drugs-like-ozempic-cause-prevent-vision-l\" rel=\"nofollow noopener\" target=\"_blank\">according to a 2025 news release\u00a0<\/a>from the American Academy of Ophthalmology regarding studies linking vision loss and GLP-1s.\u00a0<\/p>\n<p class=\"group-source-paragraph\" data-v-4fbf7207=\"\">The Source: Information for this article was taken from reporting by the Wall Street Journal, New Nation, and previous reporting by FOX News and a 2025 news release from the American Academy of Ophthalmology. This story was reported from San Jose.\u00a0<\/p>\n<p>    <a href=\"https:\/\/www.livenowfox.com\/tag\/health\" class=\"tags-tag\" data-v-94395e58=\"\" rel=\"nofollow noopener\" target=\"_blank\">Health<\/a><a href=\"https:\/\/www.livenowfox.com\/tag\/us\" class=\"tags-tag\" data-v-94395e58=\"\" rel=\"nofollow noopener\" target=\"_blank\">U.S.<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"A civil lawsuit has been filed against GLP-1 drugmakers over the potential risk of sudden vision loss, according&hellip;\n","protected":false},"author":2,"featured_media":632718,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[103,61,60,371,43,90],"class_list":["post-632717","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-health","tag-ie","tag-ireland","tag-medication","tag-news","tag-us"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/632717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=632717"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/632717\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/632718"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=632717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=632717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=632717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}